Pharmasset Initiates Dosing In Phase 1 PSI-938 Trial
Pharmasset has recently filed an Investigational New Drug Application (IND) with the FDA. Pharmasset said that Purine nucleoside/tide analogs have many of the benefits of pyrimidine nucleoside/tide analogs,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.